Sona Nanotech Inc. (SONA.CN)

CAD 0.26

(0.0%)

Market Cap (In CAD)

28.5 Million

Revenue (In CAD)

-

Net Income (In CAD)

-2.49 Million

Avg. Volume

27.98 Thousand

Currency
CAD
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
0.22-0.56
PE
-
EPS
-
Beta Value
-1.724
ISIN
CA83541C1059
CUSIP
-
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Medical - Diagnostics & Research
CEO
Mr. David Andrew Regan
Employee Count
-
Website
https://www.sonanano.com
Ipo Date
2006-07-14
Details
Sona Nanotech Inc., nanotechnology life sciences company, manufactures and sells gold nanorod products for diagnostic tests. The company also provides Nanotech COVID-19 Lateral Flow Assay, an immunochromatographic assay for the detection of the spike protein antigen from SARS-CoV-2 in saliva specimens from individuals, who are suspected of COVID-19; Gemini gold nanorods; Omni gold nanorods for medical applications; and contract services. Its products are used in various applications, including drug delivery, food and beverage testing, environmental testing, cell imaging, cancer treatment, and liposuction therapy, as well as medical and consumer, military, and veterinary diagnostics. The company is based in Halifax, Canada.

More Stocks